Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (36)Subcutaneous Saphnelo approved in EU
Preheader (121)Saphnelo approved in the EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus
Typography
Arial
Colors
Text Analysis
Body Words120
Subject Words5
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px720 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekTuesday
TimeMorning

Subcutaneous Saphnelo approved in EU

Saphnelo approved in the EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus
Subcutaneous Saphnelo approved in EU